NEW YORK (GenomeWeb News) – Exact Sciences has raised $137.7 million in net proceeds from a public offering of 11.5 million shares of common stock.

The firm priced the shares at $12.75 each, which brought in gross proceeds of $146.6 million. Exact Sciences priced the offering of 10 million shares last week. The underwriters on the offering exercised their 1.5 million-share overallotment option in full.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.